Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 14/20 | 0.54 |
| ▸ | CCKAR | P32238 | 10/20 | 0.54 |
| ▸ | NOTCH1 | P46531 | 2/20 | 0.40 |
| ▸ | NOTCH3 | Q9UM47 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20098111 | 1.00 | CCKBR (0.54) | CCKBRCCKARNOTCH1NOTCH3 | |
| SCHEMBL21755134 | 0.89 | CCKBR (0.52) | CCKBRCCKAR | |
| SCHEMBL20098289 | 0.89 | CCKBR (0.52) | CCKBRCCKAR | |
| SCHEMBL21755277 | 0.88 | CCKBR (0.61) | CCKBRCCKAR | |
| SCHEMBL20098119 | 0.88 | CCKBR (0.61) | CCKBRCCKAR | |
| SCHEMBL20867147 | 0.86 | CCKBR (0.50) | CCKBRCCKARNOTCH1NOTCH3 | |
| SCHEMBL20098158 | 0.85 | CCKBR (0.54) | CCKBRCCKAR | |
| SCHEMBL21755135 | 0.85 | CCKBR (0.54) | CCKBRCCKAR | |
| SCHEMBL24612339 | 0.85 | CCKBR (0.49) | CCKBRCCKARNOTCH1NOTCH3 | |
| SCHEMBL22440650 | 0.85 | CCKBR (0.49) | CCKBRCCKARNOTCH1NOTCH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10570153-B2 | Benzodiazepine derivatives as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2020-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570153-B2 | Benzodiazepine derivatives as RSV inhibitors | GABRA5, GABRA1, GABBR2 | CCKBR 509/4885CCKAR 989/4885NOTCH1 4777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.